Share-based Payment Arrangement, Expense of NOVAVAX INC from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NOVAVAX INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • NOVAVAX INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $8,549,000, a 29% decline year-over-year.
  • NOVAVAX INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $38,496,000, a 28% decline year-over-year.
  • NOVAVAX INC annual Share-based Payment Arrangement, Expense for 2024 was $48,152,000, a 44% decline from 2023.
  • NOVAVAX INC annual Share-based Payment Arrangement, Expense for 2023 was $85,357,000, a 34% decline from 2022.
  • NOVAVAX INC annual Share-based Payment Arrangement, Expense for 2022 was $130,300,000, a 29% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

NOVAVAX INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $38,496,000 $8,549,000 -$3,500,000 -29% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $41,996,000 $9,214,000 -$4,885,000 -35% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $46,881,000 $10,285,000 -$1,271,000 -11% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $48,152,000 $10,448,000 -$5,210,000 -33% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q3 2024 $53,362,000 $12,049,000 -$8,711,000 -42% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $62,073,000 $14,099,000 -$6,193,000 -31% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $68,266,000 $11,556,000 -$17,091,000 -60% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $85,357,000 $15,658,000 -$12,114,000 -44% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $97,471,000 $20,760,000 -$10,787,000 -34% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $108,258,000 $20,292,000 -$17,756,000 -47% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $126,014,000 $28,647,000 -$4,286,000 -13% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $130,300,000 $27,772,000 -$4,397,000 -14% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $134,697,000 $31,547,000 -$13,727,000 -30% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $148,424,000 $38,048,000 -$15,075,000 -28% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $163,499,000 $32,933,000 -$20,127,000 -38% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $183,626,000 $32,169,000 -$18,264,000 -36% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 $201,890,000 $45,274,000 -$20,431,000 -31% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $222,321,000 $53,123,000 +$45,191,000 +570% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $177,130,000 $53,060,000 +$49,095,000 +1238% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $128,035,000 $50,433,000 +$46,187,000 +1088% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $81,848,000 $65,705,000 +$63,081,000 +2404% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021 2021 Q3
Q2 2020 $18,767,000 $7,932,000 +$3,312,000 +72% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $15,455,000 $3,965,000 -$1,593,000 -29% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q4 2019 $17,048,000 $4,246,000 -$141,000 -3.2% 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
Q3 2019 $17,189,000 $2,624,000 -$1,807,000 -41% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $18,996,000 $4,620,000 +$369,000 +8.7% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $18,627,000 $5,558,000 +$313,000 +6% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q4 2018 $18,314,000 $4,387,000 -$2,364,000 -35% 01 Oct 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
Q3 2018 $20,678,000 $4,431,000 +$100,000 +2.3% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 $20,578,000 $4,251,000 -$263,000 -5.8% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $20,841,000 $5,245,000 +$1,032,000 +24% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q4 2017 $19,809,000 $6,751,000 +$2,965,000 +78% 01 Oct 2017 31 Dec 2017 10-K 11 Mar 2020 2019 FY
Q3 2017 $16,844,000 $4,331,000 -$825,000 -16% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 $17,669,000 $4,514,000 -$743,000 -14% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018 2018 Q2
Q1 2017 $18,412,000 $4,213,000 -$748,000 -15% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q4 2016 $19,160,000 $3,786,000 -$368,000 -8.9% 01 Oct 2016 31 Dec 2016 10-K 18 Mar 2019 2018 FY
Q3 2016 $19,528,000 $5,156,000 +$391,000 +8.2% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017 2017 Q3
Q2 2016 $19,137,000 $5,257,000 +$2,677,000 +104% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 $16,460,000 $4,961,000 +$3,029,000 +157% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017 2017 Q1
Q4 2015 $13,431,000 $4,154,000 +$2,647,000 +176% 01 Oct 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY
Q3 2015 $10,784,000 $4,765,000 +$3,074,000 +182% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 $7,710,000 $2,580,000 +$728,000 +39% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2016 Q2
Q1 2015 $6,982,000 $1,932,000 +$892,000 +86% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q4 2014 $6,090,000 $1,507,000 +$811,000 +117% 01 Oct 2014 31 Dec 2014 10-K 27 Feb 2017 2016 FY
Q3 2014 $5,279,000 $1,691,000 +$1,028,000 +155% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2015 Q3
Q2 2014 $4,251,000 $1,852,000 +$1,214,000 +190% 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015 2015 Q2
Q1 2014 $3,037,000 $1,040,000 +$557,000 +115% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q4 2013 $2,480,000 $696,000 +$274,000 +65% 01 Oct 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
Q3 2013 $2,206,000 $663,000 +$170,000 +34% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014 2014 Q3
Q2 2013 $2,036,000 $638,000 +$49,000 +8.3% 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014 2014 Q2
Q1 2013 $1,987,000 $483,000 -$104,000 -18% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q4 2012 $2,091,000 $422,000 01 Oct 2012 31 Dec 2012 10-K 27 Feb 2015 2014 FY
Q3 2012 $493,000 -$49,000 -9% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013 2013 Q3
Q2 2012 $589,000 -$114,000 -16% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2013 2013 Q2
Q1 2012 $587,000 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013 2013 Q1
Q3 2011 $542,000 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012 2012 Q3
Q2 2011 $703,000 01 Apr 2011 30 Jun 2011 10-Q 09 Aug 2012 2012 Q2

NOVAVAX INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $48,152,000 -$37,205,000 -44% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
2023 $85,357,000 -$44,943,000 -34% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $130,300,000 -$53,326,000 -29% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $183,626,000 +$55,591,000 +43% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $128,035,000 +$110,987,000 +651% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $17,048,000 -$1,266,000 -6.9% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $18,314,000 -$1,495,000 -7.5% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $19,809,000 +$649,000 +3.4% 01 Jan 2017 31 Dec 2017 10-K 11 Mar 2020 2019 FY
2016 $19,160,000 +$5,729,000 +43% 01 Jan 2016 31 Dec 2016 10-K 18 Mar 2019 2018 FY
2015 $13,431,000 +$7,341,000 +121% 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY
2014 $6,090,000 +$3,610,000 +146% 01 Jan 2014 31 Dec 2014 10-K 27 Feb 2017 2016 FY
2013 $2,480,000 +$389,000 +19% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $2,091,000 +$44,000 +2.1% 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015 2014 FY
2011 $2,047,000 +$708,000 +53% 01 Jan 2011 31 Dec 2011 10-K 12 Mar 2014 2013 FY
2010 $1,339,000 01 Jan 2010 31 Dec 2010 10-K 12 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.